| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 6 |
| 1 | ANASTROZOLE | 4 |
| 2 | ANASTROZOLE TABLETS | 4 |
| 3 | LETROZOLE | 4 |
| 4 | LETROZOLE TABLETS | 4 |
| 5 | LEUPROLIDE ACETATE | 4 |
| 6 | RIBOCICLIB | 4 |
| 7 | METHOTREXATE SODIUM | 3 |
| 8 | RISANKIZUMAB-RZAA | 3 |
| 9 | RITUXIMAB-ABBS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RITUXIMAB-ABBS | 3 | 0.0006 |
| 1 | RISDIPLAM | 1 | 0.0002 |
| 2 | CABERGOLINE | 1 | 0.0002 |
| 3 | ANASTROZOLE TABLETS | 4 | 0.0002 |
| 4 | FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% | 1 | 0.0002 |
| 5 | RIBOCICLIB | 4 | 0.0001 |
| 6 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 7 | ANASTROZOLE | 4 | 0.0001 |
| 8 | LETROZOLE TABLETS | 4 | 0.0001 |
| 9 | LETROZOLE | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 1 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 2 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 3 | Aromatase Inhibitor [EPC] | 4 | 0.0000 |
| 4 | RANK Ligand Inhibitor [EPC] | 6 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 6 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 9 | Estrogen [EPC] | 1 | 0.0000 |